Eloise Chapman, MD

Highlights

1
Journal of general internal medicine · 2020
ECEloise Chapman MFMelissa Frey
PMID: 32720237PMCID: PMC7859010DOIFirst author152 citations
2
Gynecologic oncology · 2020
MFMelissa Frey DFDavid Fishman MJMargaux Jenna Kanis PJPaul J Christos+2 more →ECEloise Chapman
PMID: 32981694PMCID: PMC7516937DOISenior author42 citations
3
Journal of lower genital tract disease · 2022
MJMegan Johnson Shen ECEvelyn Cantillo MFMelissa Frey MMMonika M Safford ECEloise Chapman
PMID: 36074132DOISenior author11 citations

97

8

6 grants

PI
Evaluating the Impact of a Novel Educational Intervention to Improve Timely Colposcopy Follow-Up and Treatment Among High-Risk Populations
National Cancer Institute · 2026–2031
R01CA300794-01A1
Co-I
Immuno-Activating Circuits Enabling Durable Control of High-Grade Serous Ovarian Cancer
U.S. Department of Defense · 2026–2030
HT9425-26-1-E334
Co-I
PICI Grant and Main Collaboration Agreement with Multiple Subprojects
Parker Institute for Cancer Immunotherapy · 2024–2028
PICI 235170-01
Co-I
Immunometabolic Programs Controlled by ER Stress in Cancer
National Cancer Institute · 2023–2028
R01CA282072-01
Co-I
Unleashing Peritoneal-Resident Memory T cells to Eliminate Ovarian Cancer
Pershing Square Foundation · 2025–2027
PSF 2519092-01
Sub-PI
The SISTER Study: Social Interventions for Support during Treatment for Endometrial cancer and Recurrence
Patient-Centered Outcomes Research Institute · 2021–2026 · via University of Washington, The
UW 203772-06

Completed grants (2)

Co-I
Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning among Advanced Cancer Patients
National Cancer Institute · 2020–2025 · via Fred Hutchinson Cancer Center· 3 renewals
R37CA246703-03
KP
XBP1 as a New Biomarker of Ovarian Cancer Progression and Therapeutic Outcome
Colleen’s Dream Foundation · 2017–2018
CDF 17070934-01

6

1 study

PI
Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
NA · University of Washington, The · OPEN TO ACCRUAL (as of 2022)
Endometrial Cancer
NCT04930159

Completed & closed trials (5)

PI
Utilization Of A Web-Based Platform (Patient Activated Learning System- PALS) To Improve Knowledge And Follow-Up Among Women With Abnormal Cervical Cancer Screening (PALS)
NA · Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2026)
Health Knowledge, Attitudes, Practice
NCT04070534
PI
Use of a web-based platform (Patient Activated Learning System) to promote knowledge, uptake, and completion of HPV Vaccination (Pediatric PALS)
Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2026)
PI
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
PHASE3 · Tesaro, Inc. · IRB STUDY CLOSURE (as of 2025)
Ovarian Neoplasms; Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
NCT03602859
PI
Impact of COVID-19 among underserved women with Gynecologic Cancer in NYC
Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2025)
PI
Patient and Provider experiences with telemedicine utilization among underserved women seeking Gynecologic care in the era of COVID-19
Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2024)

Awards & Honors: April
April 30, 2024
Awards, honors and achievements for the month of April.
In Brief: COVID-19 and Health Equity
September 2, 2020
Two papers from Weill Cornell Medicine and NewYork-Presbyterian investigators make recommendations on addressing health disparities related to COVID-19 and broader social factors that impact patient health.

Foundation for Women's Cancer